Filing Details

Accession Number:
0001104659-22-007441
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-25 17:01:17
Reporting Period:
2022-01-24
Accepted Time:
2022-01-25 17:01:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1722964 Y-Mabs Therapeutics Inc. YMAB Pharmaceutical Preparations (2834) 474619612
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752940 Bo Kruse C/O Y-Mabs Therapeutics, Inc.
230 Park Avenue Suite 3350
New York NY 10169
Evp, Cfo, Secretary & Treas. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-24 4,000 $9.84 189,077 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.